Horizon Kinetics Inflation Beneficiaries ETF (NYSEARCA:INFL – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $38.24 and last traded at $38.24, with a volume of 5921 shares traded. The stock had previously closed at $38.03.
Horizon Kinetics Inflation Beneficiaries ETF Price Performance
The firm has a market capitalization of $751.27 million, a PE ratio of 14.64 and a beta of 0.69. The firm has a fifty day moving average price of $36.04 and a 200 day moving average price of $33.96.
Hedge Funds Weigh In On Horizon Kinetics Inflation Beneficiaries ETF
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its holdings in shares of Horizon Kinetics Inflation Beneficiaries ETF by 23.5% in the second quarter. Bank of New York Mellon Corp now owns 223,372 shares of the company’s stock valued at $7,300,000 after purchasing an additional 42,538 shares in the last quarter. Hilltop National Bank lifted its stake in Horizon Kinetics Inflation Beneficiaries ETF by 12.6% in the 2nd quarter. Hilltop National Bank now owns 96,217 shares of the company’s stock worth $3,144,000 after acquiring an additional 10,802 shares in the last quarter. Finally, Lowe Wealth Advisors LLC grew its stake in Horizon Kinetics Inflation Beneficiaries ETF by 4.1% during the 2nd quarter. Lowe Wealth Advisors LLC now owns 222,824 shares of the company’s stock valued at $7,282,000 after acquiring an additional 8,799 shares in the last quarter.
Horizon Kinetics Inflation Beneficiaries ETF Company Profile
The Horizon Kinetics Inflation Beneficiaries ETF (INFL) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively-managed fund seeking long-term capital growth in inflation-adjusted terms from companies expected to benefit, directly or indirectly, from inflation. INFL was launched on Jan 11, 2021 and is managed by Horizon Kinetics.
Featured Stories
- Five stocks we like better than Horizon Kinetics Inflation Beneficiaries ETF
- Dividend Payout Ratio Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Investing In Preferred Stock vs. Common Stock
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Bank Stocks – Best Bank Stocks to Invest In
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Horizon Kinetics Inflation Beneficiaries ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Kinetics Inflation Beneficiaries ETF and related companies with MarketBeat.com's FREE daily email newsletter.
